IMPACT OF DONOR DIVERSITY ON PHASE I AND PHASE II ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES AND HUMAN LIVER MICROSOMES

被引：0
|
作者：
Bohl, Christopher [1 ]
Brouwer, Kenneth [2 ]
Heyward, Scott [3 ]
Cottier, Karissa [3 ]
Noah, Courtney [4 ]
Ogilvie, Brian [5 ]
机构：
[1] BioIVT, Kalamazoo, MI USA
[2] BioIVT, Durham, NC USA
[3] BioIVT, Baltimore, MD USA
[4] BioIVT, Hicksville, NY USA
[5] BioIVT, Kansas City, KS USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P27
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DEMOGRAPHIC DIFFERENCES BY AGE, BMI, GENDER AND ETHNICITY OF PHASE I AND PHASE II ENZYME ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES
    Moeller, Timothy
    Dennell, Stephen
    Rose, Terrell
    Watt, Carolyn
    Sahi, Jasminder
    DRUG METABOLISM REVIEWS, 2012, 44 : 97 - 97
  • [2] Comparison of major phase I and phase II metabolism reactions in cryopreserved dog and human hepatocytes
    Snodgrass, BR
    Gagne, PV
    Picano, PL
    Tarabelsi, LF
    Parikh, SN
    Patten, CJ
    Crespi, CL
    DRUG METABOLISM REVIEWS, 2003, 35 : 37 - 37
  • [3] A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes
    Somers, G. I.
    Lindsay, N.
    Lowdon, B. M.
    Jones, A. E.
    Freathy, C.
    Ho, S.
    Woodrooffe, A. J. M.
    Bayliss, M. K.
    Manchee, G. R.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (10) : 1797 - 1805
  • [4] Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer
    den Braver-Sewradj, Shalenie P.
    den Braver, Michiel W.
    Vermeulen, Nico P. E.
    Commandeur, Jan N. M.
    Richert, Lysiane
    Vos, J. Chris
    TOXICOLOGY IN VITRO, 2016, 33 : 71 - 79
  • [5] THE USE OF PRIMARY CRYOPRESERVED HUMAN HEPATOCYTES AS A MODEL FOR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RELATED CHANGES IN PHASE I AND PHASE II ENZYME ACTIVITIES
    Cottier, Karissa
    Le, Xuan
    Heyward, Scott
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S31 - S32
  • [6] Major phase I biotransformation pathways of trichostatin A in rat hepatocytes and in rat and human liver microsomes
    Elaut, G
    Török, G
    Vinken, M
    Laus, G
    Papeleu, P
    Tourwe, D
    Rogiers, V
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1320 - 1328
  • [7] In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol
    Negreira, Noelia
    Erratico, Claudio
    Kosjek, Tina
    van Nuijs, Alexander L. N.
    Heath, Ester
    Neels, Hugo
    Covaci, Adrian
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2015, 407 (19) : 5803 - 5816
  • [8] In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol
    Noelia Negreira
    Claudio Erratico
    Tina Kosjek
    Alexander L. N. van Nuijs
    Ester Heath
    Hugo Neels
    Adrian Covaci
    Analytical and Bioanalytical Chemistry, 2015, 407 : 5803 - 5816
  • [9] In vitro phase I metabolism of vinclozolin by human liver microsomes
    Cruz-Hurtado, Marycarmen
    de Lourdes Lopez-Gonzalez, Ma
    Mondragon, Victor
    Sierra-Santoyo, Adolfo
    XENOBIOTICA, 2019, 49 (08) : 895 - 904
  • [10] Identification of novel phase I and phase IImetabolites of maraviroc using human liver microsomes
    Lu, Yanhui
    Hendrix, Craig W.
    Bumpus, Namandje N.
    DRUG METABOLISM REVIEWS, 2011, 43 : 160 - 161
12345